Exact Sciences Corp. (EXAS)

Trade EXAS now with
12/16/2022 10:11:05 AM Exact Sciences Spikes 23%
6/21/2022 6:03:30 AM Ultima Genomics And Exact Sciences Enter Long-term Supply Deal For Ultima's Next-generation Sequencing Technologies
5/27/2022 8:51:54 AM Exact Sciences Showcases Breadth Of Early Detection And Treatment Guidance Portfolio At ASCO
8/16/2021 6:02:09 AM Exact Sciences Says Japan's Ministry Of Health, Labor And Welfare Approves Oncotype DX Breast Recurrence Score Program
8/13/2021 9:02:48 AM Exact Sciences' Oncoguard Liver Liquid Biopsy Test Delivers Enhanced Performance For Early-stage Detection Of HCC
5/18/2021 8:57:45 PM Exact Sciences Welcomes Final Task Force Recommendation That Lowers Starting Age For Colorectal Cancer Screening To 45
4/14/2021 6:03:21 AM Exact Sciences Completes Acquisition Of Ashion Analytics
1/10/2021 7:53:34 PM Exact Sciences Expects Q4 Total Revenue Of $464.5 Mln- $467.5 Mln
1/5/2021 8:39:59 AM Exact Sciences Completes Acquisition Of Thrive Earlier Detection
1/7/2019 7:44:56 AM William Blair Reiterates EXACT Sciences Corp. (EXAS) At Outperform
5/31/2017 9:12:23 AM Canaccord Is Increasing EXACT Sciences Corp. (EXAS) 2019 Estimate To 0.01 From -0.02
5/31/2017 9:11:34 AM Canaccord Is Raising EXACT Sciences Corp. (EXAS) 2018 Estimate To -0.94 From -0.97
5/31/2017 9:11:05 AM Canaccord Is Increasing EXACT Sciences Corp. (EXAS) 2017 Estimate To -1.41 From -1.42